Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial
Titel:
Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial
Auteur:
Hegewisch-Becker, Susanna Nöpel-Dünnebacke, Stefanie Hinke, Axel Graeven, Ullrich Reinacher-Schick, Anke Hertel, Jan Lerchenmüller, Christian A. Killing, Birgitta Depenbusch, Reinhard Al-Batran, Salah-Eddin Lange, Thoralf Dietrich, Georg Tannapfel, Andrea Arnold, Dirk